RGX-104 hydrochloride (SB742881) is a synthetic Liver X Receptor (LXR) agonist. Its transcriptional activation of the ApoE gene underlies its immunomodulatory and potential anti-cancer properties, which have been investigated in both cellular assays and animal models of oncology and immunology.